| scholarly article | Q13442814 |
| P2093 | author name string | Vincent Jarlier | |
| Emmanuelle Cambau | |||
| Alexandra Aubry | |||
| Stéphanie Matrat | |||
| Audrey Mérens | |||
| Jean-Didier Cavallo | |||
| Christine Lascols | |||
| Claude-James Soussy | |||
| P2860 | cites work | Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87). | Q39477717 |
| Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase | Q39607881 | ||
| Mycobacterial cell wall: structure and role in natural resistance to antibiotics | Q40648841 | ||
| Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. | Q41008865 | ||
| Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones | Q41825585 | ||
| Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants | Q42618006 | ||
| Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli | Q42727492 | ||
| The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions | Q44148098 | ||
| Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase | Q46377091 | ||
| An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity | Q46824415 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica | Q50079326 | ||
| First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis. | Q53608367 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance. | Q54619902 | ||
| Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005 | Q61248547 | ||
| Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 | ||
| Characterization of two potentially universal turn motifs that shape the repeated five-residues fold--crystal structure of a lumenal pentapeptide repeat protein from Cyanothece 51142 | Q24648111 | ||
| Pentapeptide repeat proteins | Q24653739 | ||
| Structure and distribution of pentapeptide repeats in bacteria | Q24673061 | ||
| Crystal structure of the breakage-reunion domain of DNA gyrase | Q27742546 | ||
| Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity | Q28486793 | ||
| American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America | Q29391534 | ||
| Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA | Q32035273 | ||
| The action of the bacterial toxin, microcin B17, on DNA gyrase | Q33271871 | ||
| Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase | Q33556397 | ||
| Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV | Q33883611 | ||
| A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. | Q33987554 | ||
| Mechanism of plasmid-mediated quinolone resistance | Q34025874 | ||
| The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action | Q34092838 | ||
| Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones | Q34352135 | ||
| Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae | Q34434110 | ||
| qnrB, another plasmid-mediated gene for quinolone resistance | Q34510366 | ||
| The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
| Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China | Q35102456 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Fluoroquinolones, tuberculosis, and resistance | Q35167433 | ||
| Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents | Q35354154 | ||
| Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases | Q35771555 | ||
| Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli | Q35879095 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| Efflux-mediated antimicrobial resistance | Q36138147 | ||
| Mechanisms of resistance to quinolones | Q36155441 | ||
| Protein mimicry of DNA and pathway regulation | Q36287050 | ||
| qnr Gene nomenclature | Q36744808 | ||
| Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones | Q36804000 | ||
| The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). | Q39117573 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quinolones | Q426549 |
| P304 | page(s) | 1587-1594 | |
| P577 | publication date | 2008-12-05 | |
| P1433 | published in | Journal of Bacteriology | Q478419 |
| P1476 | title | The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex | |
| P478 | volume | 191 |
| Q36684174 | Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates. |
| Q39210590 | DNA Replication in Mycobacterium tuberculosis |
| Q40623215 | High prevalence of plasmid-mediated quinolone resistance determinants in Enterobacter cloacae isolated from hospitals of the Qazvin, Alborz, and Tehran provinces, Iran. |
| Q35960942 | Interactions between QnrB, QnrB mutants, and DNA gyrase |
| Q55445576 | Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice. |
| Q42201141 | Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. |
| Q64058655 | Kctd9 Deficiency Impairs Natural Killer Cell Development and Effector Function |
| Q36225422 | Mechanisms of drug resistance: quinolone resistance |
| Q91762059 | Mobilome and Resistome Reconstruction from Genomes Belonging to Members of the Bifidobacterium Genus |
| Q36619820 | Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance |
| Q36757607 | Phylogenetic analysis of chromosomally determined qnr and related proteins |
| Q34888920 | Plasmid-mediated quinolone resistance |
| Q24645356 | Plasmid-mediated quinolone resistance: a multifaceted threat |
| Q34019104 | Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure |
| Q36158288 | Protective effect of Qnr on agents other than quinolones that target DNA gyrase |
| Q34339689 | Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development. |
| Q33909989 | QnrS1 structure-activity relationships |
| Q38262589 | Squaring up to DNA: pentapeptide repeat proteins and DNA mimicry |
| Q34483705 | Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor |
| Q27666560 | Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a Gram-negative bacterium |
| Q27667906 | Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor |
| Q92633491 | The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents |
| Q92154411 | The plasmid-borne quinolone resistance protein QnrB, a novel DnaA-binding protein, increases the bacterial mutation rate by triggering DNA replication stress |
| Q52646354 | Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance. |
| Q46613232 | qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis |
Search more.